A new study published in the American Journal of Transplantation reveals that racial disparities exist in both the early and late steps in access to kidney transplantation. This study is part of the February special themed ...
Feb 9, 2012
0
0
In a study to be presented today at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting, in Dallas, Texas, researchers will report findings that indicate that women who deliver their first baby ...
Feb 9, 2012
0
0
After a four-week course of the vasodilator hormone relaxin, kidney function and blood flow immediately improved in lab rats genetically altered to model polycystic kidney disease (PKD), a life-threatening genetic disorder, ...
Dec 6, 2011
0
0
An analytical technique using high brilliance infrared light produced by the SOLEIL synchrotron has been developed by teams from the CNRS, Paris Sud University, Tenon Hospital in Paris, and the Stoke-on-Trent Cancer Centre ...
Nov 29, 2011
0
0
Newly published research shows that more patients with end-stage renal disease (ESRD) caused by lupus nephritis choose hemodialysis as their initial kidney replacement therapy over peritoneal dialysis and preemptive kidney ...
Nov 7, 2011
0
0
It has become increasingly clear that patients in the United States are starting dialysis at higher and higher levels of kidney function. A team of researchers, led by Dr. Ann O'Hare, University of Washington associate professor ...
Oct 11, 2011
0
0
Adolescents and young adults who had persistent, microscopic blood in their urine (hematuria) were more likely to develop end-stage renal disease over a follow-up period of about 20 years, although the absolute risk was low, ...
Aug 16, 2011
0
0
UCSF researchers have designed a model filtration system that could offer a new approach to treating patients suffering from end-stage renal disease, potentially removing the need for a clinic-based dialysis process altogether.
Jun 17, 2011
0
0
Patients in the early stages of chronic kidney disease who had elevated levels of the endocrine hormone fibroblast growth factor 23 (that regulates phosphorus metabolism) had an associated increased risk of end-stage renal ...
Jun 14, 2011
0
0
The angiotensin-converting enzyme (ACE) inhibitor drug, ramipril, is particularly effective in lowering the risk of end-stage renal disease (ESRD) in obese patients, according to a study appearing in an upcoming issue of ...
Apr 28, 2011
0
0
